GI & Endoscopy

Here are four updates on GI companies from the past week:

Chemistry World reported on Takeda's vision for the future; it involves a move away from generics and over-the-counter businesses into pharmaceutical research and development.

Biomerica began a clinical study of its new, proprietary Helicobacter pylori test.

Medscape featured proton pump inhibitors on a list of 11 drugs physicians should consider deprescribing.

Douglas Brouillette, MD, is a gastroenterologist at Omaha, Neb.-based Midwest Gastrointestinal Associates.

Omaha, Neb.-based Lakeside Endoscopy Center has been serving Omaha and its surrounding communities since 2006.

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Sept. 5 to Sept. 8, 2017.

In 2015, approximately 114,089 physicians specialized in internal medicine making it the leading specialty among active physicians. Of all active physicians in the U.S., 567,845 physicians were male and 292,003 were female.

The American Gastroenterological Association and The Crohn's & Colitis Foundation, along with Pfizer, issued a request for proposal to solicit best practices related to improving shared decision making and promoting effective health communication between inflammatory bowel disease patients and their…

A study, presented at 2017 Digestive Disease Week, examined how eliminating financial disincentives would impact colorectal cancer screening quality, Gastroenterology and Endoscopy News reports.